A Governor General’s Gold Medal, and more, for Anne-Julie Tessier
Anne-Julie Tessier earned her doctoral degree in the laboratory of RI-MUHC scientist Stéphanie Chevalier
Taking opioids at home after surgery: More harms than benefits
A new study conducted at the RI-MUHC concludes that prescribing opioid analgesics at discharge after surgery does not reduce postoperative pain...
RI-MUHC trainee receives oral presentation prize from Canadian Conference on Ovarian Cancer Research
Doctoral student Wejdan Alenezi proposes new genes to predict ovarian...
RI-MUHC trainee awarded 2022 Vanier Canada Graduate Scholarship
Joan Miguel Romero is investigating T cell−inflammation in pancreatic cancer
RI-MUHC trainee honoured by the American Association for Cancer Research
Yasmine Benslimane is investigating how the female hormone estrogen influences the spread of colon cancer...
LSD, a future antianxiety pill?
A new study by Dr. Gabriella Gobbi reveals the neurobiological mechanisms by which LSD could relieve anxiety
Spotlight paper in World Journal of Hepatology: Alshaima Al Hinai
Recognition for former RI-MUHC trainee’s work on nonalcoholic fatty liver disease
Beyond basic research: Coming to grips with a rare disease experience
To honour Rare Disease Day on February 28, an RI-MUHC research trainee shares the perspective he gained as a patient
February 2022 winner of the Relève étoile Jacques-Genest award
Congratulations to Dominique Geoffrion, former doctoral student at the RI-MUHC!
CTN study tests new drug for the first time in people living with HIV
Postdoc Léna Royston aims to understand how cytomegalovirus infection can increase inflammation and cause health issues